Dexamethasone Sodium Phosphate NDC 25021-053

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-053Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0053Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-053-01	25021005301	25 VIAL in 1 CARTON (25021-053-01) / 1 mL in 1 VIALMarketed from Dec 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexamethasone Sodium Phosphate
Generic name (nonproprietary): dexamethasone sodium phosphate
Active ingredients: Dexamethasone sodium phosphate — 10 mg/mL
Dosage form: Injection, Solution
Route: Intra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue
Labeler: Sagent Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215654
Marketing start: Dec 1, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 25021-053_d68d6aab-10d8-4333-9fe8-a0386f8caa07SPL ID d68d6aab-10d8-4333-9fe8-a0386f8caa07SPL set ID 4680d517-ed5a-4137-819c-122ee962a464RxCUI 1116927, 1812079, 1812194UNII AI9376Y64P
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021005301 followed by a unit qualifier and the quantity

Package 25021-0053-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 6, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE A. Intravenous or Intramuscular Administration When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). Acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215654

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215654
Product	Strength	Form · route	Labeler	Product NDC
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	InjectionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Gland Pharma Limited	68083-473
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	InjectionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Gland Pharma Limited	68083-474
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Sagent Pharmaceuticals	25021-052
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	REMEDYREPACK INC.	70518-4372
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Medical Purchasing Solutions, LLC.	71872-7347
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	InjectionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Gland Pharma Limited	68083-607